No takes yet. Share an insight, caveat, or question.
Cohort study reveals significant predictors of postrelapse survival in neuroblastoma, suggesting improved risk stratification for clinical trials of novel therapies.
London et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: